New route for the activation of poly(ADP-ribose) polymerase-1: a passage that links poly(ADP-ribose) polymerase-1 to lipotoxicity?

被引:3
|
作者
Bai, Peter [1 ,2 ,3 ]
Csoka, Balazs [4 ,5 ]
机构
[1] Univ Debrecen, Dept Med Chem, H-4032 Debrecen, Hungary
[2] MTA DE Lendulet Lab Cellular Metab Res Grp, H-4032 Debrecen, Hungary
[3] Univ Debrecen, Res Ctr Mol Med, H-4032 Debrecen, Hungary
[4] Rutgers State Univ, Dept Surg, New Jersey Med Sch, Newark, NJ 07103 USA
[5] Rutgers State Univ, Ctr Immun & Inflammat, New Jersey Med Sch, Newark, NJ 07103 USA
关键词
ACBD3; cholesterol; ERK; fatty acid; lipotoxicity; PARP; DIFFERENTIATION; EXPRESSION; BINDING; ACBD3; DNA;
D O I
10.1042/BJ20150598
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this issue of Biochemical Journal, Chen and colleagues characterize an interaction between ACBD3 (acyl-CoA-binding domain-containing 3) protein and PARP [poly(ADP-ribose) polymerase]-1 through the activation of ERKs (extracellular-signal-regulated kinases). This study envisages a pathway through which ABCD3 translates enhanced fatty acid levels to ERK and consequently PARP-1 activation. The consequences of PARP-1 activation lead to cellular and tissue damage, implying that the ACBD3/PARP-1 pathway is an important pathway in lipotoxicity events.
引用
收藏
页码:E9 / E11
页数:3
相关论文
共 50 条
  • [1] Poly ADP-ribose polymerase-1 and health
    Kirkland, James B.
    [J]. EXPERIMENTAL BIOLOGY AND MEDICINE, 2010, 235 (05) : 561 - 568
  • [2] Ubiquitination of poly (ADP-ribose) polymerase-1
    Wang, T
    Simbulan-Rosenthal, CM
    Smulson, ME
    Yang, DCH
    [J]. FASEB JOURNAL, 2003, 17 (04): : A182 - A183
  • [3] Bioenergetic consequences of poly(ADP-ribose) polymerase-1 activation
    Tang, K. S.
    Suh, S. W.
    Swanson, R. A.
    Anderson, C. M.
    [J]. PROCEEDINGS OF THE VIII EUROPEAN MEETING ON GLIAL CELLS IN HEALTH AND DISEASE, 2007, : 113 - +
  • [4] Novel poly(ADP-ribose) polymerase-1 inhibitors
    Dunn, Derek
    Husten, Jean
    Ator, Mark A.
    Chatterjee, Sankar
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (01) : 222 - 224
  • [5] Novel poly(ADP-ribose) polymerase-1 inhibitors
    Dunn, Derek
    Husten, Jean
    Ator, Mark A.
    Chatterjee, Sankar
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (02) : 542 - 545
  • [6] Natural Inhibitors of Poly(ADP-ribose) Polymerase-1
    Banasik, Marek
    Stedeford, Todd
    Strosznajder, Robert P.
    [J]. MOLECULAR NEUROBIOLOGY, 2012, 46 (01) : 55 - 63
  • [7] Poly(ADP-ribose) polymerase-1 in the nervous system
    Ha, HC
    Snyder, SH
    [J]. NEUROBIOLOGY OF DISEASE, 2000, 7 (04) : 225 - 239
  • [8] Biological activity of poly(ADP-ribose)polymerase-1
    Kilianska, Zofia M.
    Zolnierczyk, Jolanta
    Wesierska-Gadek, Jozefa
    [J]. POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2010, 64 : 344 - 363
  • [9] Natural Inhibitors of Poly(ADP-ribose) Polymerase-1
    Marek Banasik
    Todd Stedeford
    Robert P. Strosznajder
    [J]. Molecular Neurobiology, 2012, 46 : 55 - 63
  • [10] Proteomic Investigation of Phosphorylation Sites in Poly(ADP-ribose) Polymerase-1 and Poly(ADP-ribose) Glycohydrolase
    Gagne, Jean-Philippe
    Moreel, Xavier
    Gagne, Pierre
    Labelle, Yves
    Droit, Arnaud
    Chevalier-Pare, Melissa
    Bourassa, Sylvie
    McDonald, Darin
    Hendzel, Michael J.
    Prigent, Claude
    Poirier, Guy G.
    [J]. JOURNAL OF PROTEOME RESEARCH, 2009, 8 (02) : 1014 - 1029